The abilities of improved schizophrenia patients to work and live independently in the community: A 10-year long-term outcome study from Mumbai, India

Annals of General Psychiatry

Volumn 8, Issue , 2009, Pages 24-

  Srivastava, Amresh K ^a,b   Stitt, Larry ^b   Thakar, Meghana ^a   Shah, Nilesh ^c   Chinnasamy, Gurusamy ^b  

^a Silver Mind Hospital   (India)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF MUMBAI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMMUNITY CARE; CONTROLLED STUDY; CONVALESCENCE; EMPLOYMENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INDEPENDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SOCIAL ASPECT; SOCIAL STATUS; SOCIAL SUPPORT; TREATMENT DURATION; URBAN AREA; WORK CAPACITY; WORK RESUMPTION;

EID: 70450260593     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-8-24     Document Type: Article

References (56)

1. Lay B, Blanz B, Hartmann M, Schmidt MH. The psychosocial outcome of adolescent-onset schizophrenia: a 12-year follow-up. Schizophr Bull 2000, 26:801-816.
2. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? a 15-year multi-follow-up study. Schizophr Bull 2005, 31:723-734. 10.1093/schbul/sbi026, 16020553.
3. Trivedi JK, Sareen H, Dhyani M. Rapid urbanization - its impact on mental health: a South Asian perspective. Indian J Psychiatry 2008, 50:161-165. 10.4103/0019-5545.43623, 2738359, 19742238.
4. Desai NG. Public mental health: an evolving imperative. Indian J Psychiatry 2006, 48:135-137.
5. Wikipedia list of metropolitan areas by population. , http://en.wikipedia.org/wiki/List_of_metropolitan_areas_by_population
6. Svedberg B, Mesterton A, Cullberg J. First-episode non-affective psychosis in a total urban population: a 5-year follow-up. Soc Psychiatry Psychiatr Epidemiol 2001, 36:332-337. 10.1007/s001270170037, 11606001.
7. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts" what we know in 2. epidemiology and etiology. Schizophr Res 2008, 102:1-18. 10.1016/j.schres.2008.04.011, 18514488.
8. Coid JW, Kirkbride JB, Barker D, Cowden F, Stamps R, Yang M, Jones PB. Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry 2008, 65:1250-1258. 10.1001/archpsyc.65.11.1250, 18981336.
9. Reichert A, Kreiker S, Mehler-Wex C, Warnke A. The psychopathological and psychosocial outcome of early-onset schizophrenia: preliminary data of a 13-year follow-up. Child Adolesc Psychiatry Ment Health 2008, 2:6. 10.1186/1753-2000-2-6, 2291029, 18304312.
10. van Os J, Krabbendam L, Myin-Germeys I, Delespaul P. The schizophrenia envirome. Curr Opin Psychiatry 2005, 18:141-145.
11. Guy W. Clinical Global Impression (CGI): ECDEU assessment manual for psychopharmacology. 1976, Rockville, MD, USA: US Department of Health, Education and Welfare.
12. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
14. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Washington DC, USA: American Psychiatric Association, 4.
15. World Health Organization WHO QoL study protocol. 1993, Geneva, Switzerland: World Health Organization.
16. Brannigan GG, Decker SL. The Bender-Gestalt II. Am J Orthopsychiatry 2006, 76:10-12. 10.1037/0002-9432.76.1.10, 16569120.
17. Herman DO, Heights J. Development of the Wechsler memory scale-revised. Clinical Neuropsychologist 1988, 2:2102-2110.
18. National Institute of Mental Health Abnormal involuntary movement scale (AIMS). Early Clin Drug Eval Unit Intercom 1975, 4:3-6.
19. Lieberman JA, Drake RE, Sederer LI, Belger A, Keefe R, Perkins D, Stroup S. Science and recovery in schizophrenia. Psychiatr Serv 2008, 59:487-496. 10.1176/appi.ps.59.5.487, 18451003.
20. Nasrallah HA, Targum SD, Tandon R, McCombs JS, Ross R. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr Serv 2005, 56:273-282. 10.1176/appi.ps.56.3.273, 15746501.
21. Buckley PF. Update on the treatment and management of schizophrenia and bipolar disorder. CNS Spectr 2008, 13(Suppl 1):1-10.
22. Prevoo MLL, van Gestel AM, van Thof MA, van Rijswjk MH, van Emsley R, Oosthuizen P. The new and evolving pharmacotherapy of schizophrenia. Psychiatr Clin North Am 2003, 26:141-163. 10.1016/S0193-953X(02)00016-3, 12683264.
23. Westermeyer JF, Harrow M. Prognosis and outcome using broad (DSM-II) and narrow (DSM-III) concepts of schizophrenia. Schizophr Bull 1984, 10:624-637.
24. Harrow M, Sands JR, Silverstein ML, Goldberg JF. Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr Bull 1997, 23:287-303.
25. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T. Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995, 167:596-603. 10.1192/bjp.167.5.596, 8564314.
26. Harrow M, Jobe TH. Longitudinal studies of outcome and recovery in schizophrenia and early intervention: can they make a difference?. Can J Psychiatry 2005, 50:879-880.
27. Harvey CA, Jeffreys SE, McNaught AS, Blizard RA, King MB. The Camden schizophrenia surveys: III. Five-year outcome of a sample of individuals from a prevalence survey and the importance of social relationships. Int J Soc Psychiatry 2007, 53:340-356. 10.1177/0020764006074529, 17703650.
28. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, León CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001, 178:506-517. 10.1192/bjp.178.6.506, 11388966.
29. Dube KC, Kumar N, Dube S. Long term course and outcome of the Agra cases in the international pilot study of schizophrenia. Acta Psychiatr Scand 1984, 70:170-179. 10.1111/j.1600-0447.1984.tb01195.x, 6485851.
30. Patel V, Cohen A, Thara R, Gureje O. Is the outcome of schizophrenia really better in developing countries?. Rev Bras Psiquiatr 2006, 28:149-152. 10.1590/S1516-44462006000200014, 16810400.
31. Drake RE, McHugo GJ, Xie H, Fox M, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull 2006, 32:464-473. 10.1093/schbul/sbj064, 2632251, 16525088.
32. Röpcke B, Eggers C. Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry 2005, 14:341-350. 10.1007/s00787-005-0483-6, 16220219.
33. Kobayashi T, Kato S. Psychopathology and outcome of first-admission schizophrenic patients: hypochondriac-cenestopathic symptoms as predictors of an unfavorable outcome. Psychiatry Clin Neurosci 2004, 58:567-572. 10.1111/j.1440-1819.2004.01301.x, 15482590.
34. Rosen K, Garety P. Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 2005, 31:735-750. 10.1093/schbul/sbi017, 16123527.
35. Craig TJ, Siegel C, Hopper K, Lin S, Sartorius N. Outcome in schizophrenia and related disorders compared between developing and developed countries: a recursive partitioning re-analysis of the WHO DOSMD data. Br J Psychiatry 1997, 170:229-233. 10.1192/bjp.170.3.229, 9229028.
36. Watt DC, Katz K, Shepherd M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med 1983, 13:663-670. 10.1017/S0033291700048091, 6353463.
37. Kulhara P, Wig NN. The chronicity of schizophrenia in North West India: results of a follow-up study. Br J Psychiatry 1978, 132:186-190. 10.1192/bjp.132.2.186, 623954.
38. Leff J, Sartorius N, Jablensky A, Korten A, Ernberg G. The international pilot study of schizophrenia: five-year follow-up findings. Psychol Med 1992, 22:131-145. 10.1017/S0033291700032797, 1574549.
39. Shepherd M, Watt D, Falloon I, Smeeton N. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl 1989, 15:1-46. 10.1017/S026418010000059X, 2798648.
40. Munk-Jørgensen P, Mortensen PB. Schizophrenia: a 13-year follow-up, diagnostic and psychopathological aspects. Acta Psychiatr Scand 1989, 79:391-399. 10.1111/j.1600-0447.1989.tb10275.x, 2735210.
41. Kulhara P, Chakrabarti S. Culture and schizophrenia and other psychotic disorders. Psychiatr Clin North Am 2001, 24:449-464. 10.1016/S0193-953X(05)70240-9, 11593856.
42. Susser E, Varma VK, Mattoo SK, Finnerty M, Mojtabai R, Tripathi BM, Misra AK, Wig NN. Long-term course of acute brief psychosis in a developing country setting. Br J Psychiatry 1998, 173:226-230. 10.1192/bjp.173.3.226, 9926098.
43. Mojtabai R, Varma VK, Malhotra S, Mattoo SK, Misra AK, Wig NN, Susser E. Mortality and long-term course in schizophrenia with a poor 2-year course: a study in a developing country. Br J Psychiatry 2001, 178:71-75. 10.1192/bjp.178.1.71, 11136214.
44. Thara R, Eaton WW. Outcome of schizophrenia: the Madras longitudinal study. Aust NZ J Psychiatry 1996, 30:516-522.
45. Dragomirecká E, Skoda C. An international study of the course and outcome of schizophrenia coordinated by the World Health Organization. Cesk Psychiatr 1992, 88:245-251.
46. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO collaborative study on determinants of outcome of severe mental disorders. Psychol Med 1986, 16:909-928. 10.1017/S0033291700011910, 3493497.
47. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry 1974, 31:37-42.
48. Malhotra S, Malhotra S. Acute and transient psychotic disorders: comparison with schizophrenia. Curr Psychiatry Rep 2003, 5:178-186. 10.1007/s11920-003-0039-8, 12773269.
49. Marcolin MA. The prognosis of schizophrenia across cultures. Ethn Dis 1991, 1:99-104.
50. Douki S, Nacef F, Benzineb S, Ben Amor C. Schizophrenia and culture: reality and perspectives based on the Tunisian experience. Encephale 2007, 33:21-29. 10.1016/S0013-7006(07)91555-9, 17457291.
51. Thirthalli J, Jain S. Better outcome of schizophrenia in India: a natural selection against severe forms?. Schizophr Bull 2009, 35:655-657. 10.1093/schbul/sbn012, 18339655.
52. Tsoi WF, Wong KE. A 15-year follow-up study of Chinese schizophrenic patients. Acta Psychiatr Scand 1991, 84:217-220. 10.1111/j.1600-0447.1991.tb03132.x, 1950620.
53. Meltzer HY. Outcome in schizophrenia: beyond symptom reduction. J Clin Psychiatry 1999, 60:3-7.
54. Leucht S, Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006, 39:161-170. 10.1055/s-2006-949513, 16944406.
55. Lindström E, Eberhard J, Levander S. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome. Acta Psychiatr Scand Suppl 2007, 116:5-16.
56. Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol 2004, 39:337-349. 10.1007/s00127-004-0762-4, 15133589.